Titre:	Chromatographic method for determining 6‑mercaptopurine in skin permeation assays for assessing cutaneous exposure risk
Auteur(s):	Oliveira, Gabriel de Sousa Lima, Ana Luiza Gross, Idejan P. Barreto, Livia Sá Souza, Patrícia Medeiros Gratieri, Tais Gelfuso, Guilherme Martins Cunha Filho, Marcílio Sérgio Soares da
metadata.dc.identifier.orcid:	https://orcid.org/0000-0001-6481-2364 https://orcid.org/0009-0005-7175-164X https://orcid.org/0000-0002-9167-6852
metadata.dc.contributor.affiliation:	University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Faculty of Ceilandia University of Brasilia, School of Health Sciences University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC) University of Brasilia, Laboratory of Food Drugs, and Cosmetics (LTMAC)
Assunto::	Absorção Medicamentos Cromatografia a líquido de alta eficiência Profissionais da saúde Riscos ocupacionais
Date de publication:	16-jui-2025
Editeur:	American Chemical Society
Référence bibliographique:	OLIVEIRA, Gabriel de S. et al. Chromatographic method for determining 6‑mercaptopurine in skin permeation assays for assessing cutaneous exposure risk. ACS Omega, [S. l.], v. 10, n. 29, 32384-32390. DOI: https://doi.org/10.1021/acsomega.5c04686. Disponível em: https://pubs.acs.org/doi/10.1021/acsomega.5c04686. Acesso em: 10 dez. 2025.
Abstract:	6-Mercaptopurine monohydrate (6-MP) is a drug often used in leukemia chemotherapy, but limited information is available about its cutaneous absorption, which raises concerns about occupational risks for healthcare professionals and caregivers. This study aimed to validate an analytical method using high-performance liquid chromatography (HPLC) for quantifying 6-MP in the skin, allowing the assessment of its cutaneous permeation. The validation of the proposed method demonstrated high selectivity against skin interferents, linearity (R = 0.999), precision, and sensitivity, with detection and quantification limits of 0.13 μg/mL and 0.39 μg/mL, respectively. The developed extraction procedure allowed reproducible drug recovery from the stratum corneum and remaining skin, minimizing the impact of enzymatic metabolism in these biological matrices. Using the developed method, a preliminary skin permeation test on porcine skin showed that 6-MP is retained mainly in the remaining skin, accumulating approximately 2% of the total dose applied within 30 min of testing, suggesting a high risk of dermal exposure. The results reinforce the need for preventive measures, such as personal protective equipment and strict handling protocols, to minimize drug exposure. Thus, the method described constitutes an essential tool in assessing the risk of topical contamination of 6-MP and can be used in long-term studies of skin permeation of this drug, contributing to the safety of health professionals, caregivers, and patients.
metadata.dc.description.unidade:	Faculdade de Ciências da Saúde (FS) Departamento de Farmácia (FS FAR) Faculdade de Ciências e Tecnologias em Saúde (FCTS) – Campus UnB Ceilândia
metadata.dc.description.ppg:	Programa de Pós-Graduação em Ciências da Saúde
Licença::	This article is licensed under CC-BY 4.0
DOI:	https://doi.org/10.1021/acsomega.5c04686
Collection(s) :	Artigos publicados em periódicos e afins

Tous les documents dans DSpace sont protégés par copyright, avec tous droits réservés.